Form 4: Bioventus CFO Acquires Shares, Sells Some

Bioventus Inc. SVP & CFO Mark Leonard Singleton reported transactions involving Class A Common Stock, including the acquisition of restricted stock units and the sale of shares.

Summary

• Mark Leonard Singleton, SVP & CFO of Bioventus Inc., reported a transaction on April 10, 2026.
• He acquired 13,000 shares of Class A Common Stock through restricted stock units (RSUs) with a transaction code 'M' and a price of $0.
• These RSUs vest in four equal installments on the first four anniversaries of April 10, 2023, contingent on continued service.
• Additionally, Singleton sold 5,648 shares of Class A Common Stock at a price of $9.06 per share, indicated by transaction code 'F'.
• Following these transactions, Singleton beneficially owns 177,333 shares of Class A Common Stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as the acquisition of RSUs is balanced by the sale of shares, with no clear indication of significant positive or negative sentiment regarding the company's performance.

Positives

• Acquisition of 13,000 restricted stock units, indicating continued equity incentive for the CFO.
• The RSUs vest over time, aligning the CFO's interests with the company's long-term performance.
• The CFO retains a significant beneficial ownership of 177,333 shares after the reported transactions.

Negatives

• Sale of 5,648 shares of Class A Common Stock by the CFO, which could be interpreted as a reduction in direct holdings.

Future Outlook

The restricted stock units are set to vest in four equal installments on the first four anniversaries of April 10, 2023, subject to the reporting person's continued service.

Industry Context

StockSavvy.ai notes that insider transactions, such as those reported on Form 4, provide insights into the confidence management has in the company's prospects. The acquisition of RSUs suggests a positive outlook, while the sale of shares may be for personal financial planning or diversification.

Stakeholder Impact

• Shareholders may observe the CFO's stock transactions as an indicator of management's confidence, though the sale could also be for personal reasons.
• Employees may see the RSU grant as a standard incentive for executive compensation.

Next Steps

• Continued vesting of restricted stock units over the next four years, contingent on service.
• Monitoring of future insider transactions by Mark Leonard Singleton.

Key Dates

Keywords

Bioventus Inc., BVS, Form 4, Insider Trading, Stock Transaction, Restricted Stock Units, Class A Common Stock, SVP & CFO, Mark Leonard Singleton